What is a stock summary page? Click here for an overview.
Business Description
Sprint Bioscience AB
ISIN : SE0006343745
Compare
Compare
Traded in other countries / regions
SPRINT.Sweden5JA1.Germany IPO Date
2020-08-06Description
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.22 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -7.9 | |||||
| Beneish M-Score | -0.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.5 | |||||
| 3-Year EBITDA Growth Rate | 29.3 | |||||
| 3-Year EPS without NRI Growth Rate | 28.9 | |||||
| 3-Year FCF Growth Rate | 34.1 | |||||
| 3-Year Book Growth Rate | -55.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.62 | |||||
| 9-Day RSI | 55.07 | |||||
| 14-Day RSI | 47.17 | |||||
| 3-1 Month Momentum % | 41.77 | |||||
| 6-1 Month Momentum % | 58.53 | |||||
| 12-1 Month Momentum % | 91.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.14 | |||||
| Quick Ratio | 1.14 | |||||
| Cash Ratio | 0.76 | |||||
| Days Sales Outstanding | 4.46 | |||||
| Days Payable | 76.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.83 | |||||
| Operating Margin % | -29.97 | |||||
| Net Margin % | -27.84 | |||||
| FCF Margin % | -36.74 | |||||
| ROE % | -97.3 | |||||
| ROA % | -36.4 | |||||
| ROIC % | -65.17 | |||||
| 3-Year ROIIC % | 25 | |||||
| ROC (Joel Greenblatt) % | -389.84 | |||||
| ROCE % | -94.31 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.69 | |||||
| PB Ratio | 4.9 | |||||
| Price-to-Tangible-Book | 5.4 | |||||
| EV-to-EBIT | -1.22 | |||||
| EV-to-EBITDA | -1.28 | |||||
| EV-to-Revenue | 0.32 | |||||
| EV-to-FCF | -0.83 | |||||
| Price-to-GF-Value | 0.27 | |||||
| Earnings Yield (Greenblatt) % | -82.38 | |||||
| FCF Yield % | -53.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sprint Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5.776 | ||
| EPS (TTM) (€) | -0.021 | ||
| Beta | -1.39 | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.53 | ||
| Volatility % | 100 | ||
| 14-Day RSI | 47.17 | ||
| 14-Day ATR (€) | 0.007063 | ||
| 20-Day SMA (€) | 0.04598 | ||
| 12-1 Month Momentum % | 91.57 | ||
| 52-Week Range (€) | 0.0378 - 0.1678 | ||
| Shares Outstanding (Mil) | 71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sprint Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sprint Bioscience AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sprint Bioscience AB Frequently Asked Questions
What is Sprint Bioscience AB(FRA:5JA1)'s stock price today?
The current price of FRA:5JA1 is €0.05. The 52 week high of FRA:5JA1 is €0.17 and 52 week low is €0.04.
When is next earnings date of Sprint Bioscience AB(FRA:5JA1)?
The next earnings date of Sprint Bioscience AB(FRA:5JA1) is 2025-05-08 Est..
Does Sprint Bioscience AB(FRA:5JA1) pay dividends? If so, how much?
Sprint Bioscience AB(FRA:5JA1) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers